G1 Therapeutics, Inc.

GTHX · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$15,137$19,950$32,281$94,352
Short-Term Investments$45,656$45,299$49,938$0
Receivables$13,309$11,654$12,687$9,265
Inventory$13,383$12,548$12,442$13,491
Other Curr. Assets$5,500$6,451$7,663$8,995
Total Curr. Assets$92,922$95,839$114,948$126,103
Property Plant & Equip (Net)$5,580$5,985$6,384$6,780
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$187$187$187$187
Tax Assets$0$0$0$0
Other NC Assets$0$15$21$27
Total NC Assets$5,767$6,187$6,592$6,994
Other Assets$0$0$0$0
Total Assets$98,689$102,026$121,540$133,097
Liabilities
Payables$5,156$5,109$3,992$7,335
Short-Term Debt$11,412$5,946$0$0
Tax Payable$0$0$0$0
Deferred Revenue$949$396$620$686
Other Curr. Liab.$19,987$21,152$25,104$25,632
Total Curr. Liab.$37,504$32,603$29,716$33,653
LT Debt$36,552$41,143$55,897$55,922
Deferred Rev, NC$0$500$500$500
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$41$41$41$0
Total NC Liab.$36,593$41,684$56,438$56,422
Other Liabilities$0$0$0$0
Cap. Leases$3,646$3,996$4,340$4,676
Total Liabilities$74,097$74,287$86,154$90,075
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$5
Retained Earnings-$795,673-$790,204-$779,985-$769,107
AOCI$0-$0-$0-$0
Other Equity$820,260$817,938$815,366$812,124
Total Equity$24,592$27,739$35,386-$769,107
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$98,689$102,026$121,540-$679,032
Net Debt$32,827$27,139$23,616-$38,430